Outset Medical (OM) EBT Margin (2019 - 2026)

Outset Medical's (OM) quarterly EBT Margin came in at 67.33% in Q1 2026, up 1894.0% year-on-year from 3.38% in Q1 2025, and little changed on a QoQ basis from 67.17% in Q4 2025.

Outset Medical (OM) EBT Margin (2019 - 2026) Analysis & Trends

Outset Medical (OM) has 8 years of EBT Margin data on file, last reported at 67.33% in Q1 2026.

  • On a quarterly basis, EBT Margin rose 1894.0% year-over-year to 67.33% in Q1 2026; TTM through Mar 2026 was 62.96%, a 3539.0% increase from a year earlier, with the FY2025 full-year figure at 67.74%, up 4439.0% from the prior year.
  • EBT Margin for Q1 2026 stood at 67.33%, roughly flat from 67.17% in the prior quarter.
  • Over the last five years, EBT Margin for OM reached as high as 58.68% in Q2 2025 and fell as low as 174.57% in Q2 2022.
  • Historically, EBT Margin has averaged 111.22% across 5 years, with a median of 121.85% in 2023.
  • Across the five-year window, EBT Margin slumped 5492 bps in 2022 and surged 6657 bps in 2025, its largest moves.
  • Year by year, EBT Margin stood at 129.28% in 2022, then climbed by 2 bps to 126.16% in 2023, then jumped by 31 bps to 87.02% in 2024, then increased by 23 bps to 67.17% in 2025, then slipped by 0 bps to 67.33% in 2026.
  • Per Business Quant data, the three most recent EBT Margin figures were 67.33% in Q1 2026, 67.17% in Q4 2025, and 59.24% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn 12.98%
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn 14.12%
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn 18.70%
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn 22.33%
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn 27.84%
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn 22.61%
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn 9.84%
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn 4.87%
10 Outset Medical 80,106.28 -286.56 Mn 12.10 Mn -67.33%

Historic Data

Download Data
DateValue
Mar 31, 2026 -67.33%
Dec 31, 2025 -67.17%
Sep 30, 2025 -59.24%
Jun 30, 2025 -58.68%
Mar 31, 2025 -86.27%
Dec 31, 2024 -87.02%
Sep 30, 2024 -96.83%
Jun 30, 2024 -125.25%
Mar 31, 2024 -141.23%
Dec 31, 2023 -126.16%
Sep 30, 2023 -151.81%
Jun 30, 2023 -121.85%
Mar 31, 2023 -130.81%
Dec 31, 2022 -129.28%
Sep 30, 2022 -146.83%
Jun 30, 2022 -174.57%
Mar 31, 2022 -120.38%
Dec 31, 2021 -146.02%
Sep 30, 2021 -115.78%
Jun 30, 2021 -119.66%